Chronic Myeloid Leukemia on Imatinib: Managing Targeted Therapy Side Effects and Quality of Life in Long-Term Treatment
Most people with chronic-phase CML take imatinib for years or even decades. This article covers what the evidence says about managing the most common long-term side effects - nausea, edema, fatigue, and muscle cramps - and why consistent adherence matters as much as the drug itself.
Low-Dose Naltrexone for Cancer Pain: Dosing, Evidence, and Safety with Chemotherapy and Hormonal Therapies
Low-dose naltrexone (LDN) is being studied off-label for refractory cancer-related pain. This article reviews typical dosing, early clinical evidence, and key safety considerations for people on chemotherapy or hormonal therapy.
